SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Castle Biosciences says TissueCypher changed management in 90% of Barrett's patients

Published study at the American College of Surgeons Clinical Congress 2026 said clinicians changed care in 90% of cases after test results.

CSTL.O